Reported positions
Quarter-end holdings as filed
Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.
Alphabet Inc.
A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ · methodology §13F ↗
Period
$4.0B
reported valuesum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away
27
positionsALL retained default holdings for this (filer, period), including NULL-value ones
3
new stakespositions with no comparable holding in the prior quarter (kind new), 2026-03-31
6
exitspositions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
Position changes — into 2026-03-31
by shares · Δ value · filing link · how changes are classified §Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
CME GROUP INC COMposition key pos:16335 · issuer key iss:476 | new | +$1.0B | +3,484,020 | $0 | $1.0B | — | 3,484,020 | |
PLANET LABS PBC COM CL Aposition key pos:16102 · issuer key iss:1732 | add | +$355M | +3,306,252 | $630M | $985M | 31,942,641 | 35,248,893 | |
REVOLUTION MEDICINES INC COMposition key pos:15541 · issuer key iss:1842 | trim | +$53.8M | −52,577 | $266M | $320M | 3,345,102 | 3,292,525 | |
PAYPAY CORP SPONSORED ADSposition key pos:16521 · issuer key iss:1685 | new | +$66.7M | +3,125,000 | $0 | $66.7M | — | 3,125,000 | |
ETHOS TECHNOLOGIES INC CL Aposition key sid:sec:prov:0f68f3ad44e9be88a60187933019742b · issuer key cusip6:29765A | new | +$42.1M | +3,770,156 | $0 | $42.1M | — | 3,770,156 | |
RELAY THERAPEUTICS INC COMposition key pos:13232 · issuer key iss:1829 | trim | +$2.3M | −4,580 | $13.3M | $15.6M | 1,568,753 | 1,564,173 | |
MONTE ROSA THERAPEUTICS INC COMposition key sid:sec:prov:3224bd4d4c1e7dd823e99e6304f866c2 · issuer key cusip6:61225M | trim | −$424K | −60,673 | $11.7M | $11.3M | 744,948 | 684,275 | |
| pos:11515 | exit‡e | −$3.0M | −22,711 | $3.0M | $0 | 22,711 | — | |
| pos:13464 | exit‡e | −$62.8K | −383 | $62.8K | $0 | 383 | — | |
| pos:15920 | exit‡e | −$68.8M | −1,036,937 | $68.8M | $0 | 1,036,937 | — | |
| sid:sec:prov:636025167f135725718ab65e5347aeb8 | exit‡e | −$2.4M | −23,205 | $2.4M | $0 | 23,205 | — | |
| sid:sec:prov:b66dc0816f9158ee3c706ae6f74ba1a4 | exit‡e | −$161K | −14,262 | $161K | $0 | 14,262 | — | |
| sid:sec:prov:c7006294f210a079144174582bed8db0 | exit‡e | −$634K | −189,122 | $634K | $0 | 189,122 | — |
Mark-to-market only (no share change) · 19
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
AST SPACEMOBILE INC COM CL Aposition key pos:17378 · issuer key iss:33 | no change | +$91.6M | 0 | $650M | $741M | 8,943,486 | 8,943,486 | |
ARM HOLDINGS PLC SPONSORED ADSposition key pos:11356 · issuer key iss:245 | no change | +$82.3M | 0 | $214M | $297M | 1,960,784 | 1,960,784 | |
FRESHWORKS INC CLASS A COMposition key pos:15735 · issuer key iss:965 | no change | −$68.4M | 0 | $199M | $130M | 16,206,643 | 16,206,643 | |
UIPATH INC CL Aposition key pos:12507 · issuer key iss:2190 | no change | −$37.2M | 0 | $115M | $78.1M | 7,034,337 | 7,034,337 | |
TEMPUS AI INC CL Aposition key pos:13648 · issuer key iss:2103 | no change | −$21.5M | 0 | $91.6M | $70.1M | 1,551,102 | 1,551,102 | |
GITLAB INC CLASS A COMposition key sid:sec:prov:431d99b61e91bc00d72171223c54fba0 · issuer key cusip6:37637K | no change | −$43.3M | 0 | $102M | $59.0M | 2,724,712 | 2,724,712 | |
PRIME MEDICINE INC COMposition key pos:18525 · issuer key iss:1756 | no change | +$166K | 0 | $57.5M | $57.6M | 16,562,498 | 16,562,498 | |
MAZE THERAPEUTICS INC COMposition key pos:16236 · issuer key iss:1445 | no change | −$16.1M | 0 | $57.5M | $41.4M | 1,388,583 | 1,388,583 | |
BRIDGEBIO ONCOLOGY THERAPEUT COM NEWposition key pos:12931 · issuer key iss:426 | no change | −$10.1M | 0 | $35.3M | $25.3M | 2,823,126 | 2,823,126 | |
VERA THERAPEUTICS INC CL Aposition key sid:sec:prov:c6f0567aff349dfe2dab4a6ee5ba8988 · issuer key cusip6:92337R | no change | −$2.5M | 0 | $12.2M | $9.7M | 241,264 | 241,264 | |
SANA BIOTECHNOLOGY INC COMposition key sid:sec:prov:7ff2ed7cd5581a47f16a78be72caca7a · issuer key cusip6:799566 | no change | −$3.3M | 0 | $11.4M | $8.1M | 2,812,500 | 2,812,500 | |
BEAM THERAPEUTICS INC COMposition key sid:sec:prov:fbdfb263adbfc86bd605b695db4205d4 · issuer key cusip6:07373V | no change | −$1.3M | 0 | $8.9M | $7.7M | 321,604 | 321,604 | |
LYELL IMMUNOPHARMA INC COM NEWposition key sid:sec:prov:d067ef4f7c9728f5f829abdf3e437ff5 · issuer key cusip6:55083R | no change | −$3.1M | 0 | $9.0M | $5.9M | 293,256 | 293,256 | |
OSCAR HEALTH INC CL Aposition key pos:15352 · issuer key iss:1639 | no change | −$1.4M | 0 | $6.9M | $5.5M | 481,988 | 481,988 | |
FIGMA INC CLASS A COM STKposition key pos:13175 · issuer key iss:910 | no change | −$3.5M | 0 | $8.1M | $4.6M | 215,582 | 215,582 | |
SPERO THERAPEUTICS INC COMposition key sid:sec:prov:47c2c715f7794c0452a1deb614c2407a · issuer key cusip6:84833T | no change | +$8.9K | 0 | $2.1M | $2.1M | 889,979 | 889,979 | |
HYPERFINE INC COM CL Aposition key sid:sec:prov:f9f4e9d528f822d6076627a32c98535e · issuer key cusip6:44916K | no change | +$89.9K | 0 | $881K | $971K | 898,720 | 898,720 | |
AUTOLUS THERAPEUTICS PLC SPON ADSposition key sid:sec:prov:0cba59ee844ea8b6e5b356f9157cdead · issuer key cusip6:05280R | no change | −$426K | 0 | $1.4M | $964K | 698,262 | 698,262 | |
TENAYA THERAPEUTICS INC COMposition key sid:sec:prov:3ee3713be378574ddccc7774d07e4d4f · issuer key cusip6:87990A | no change | −$18.3K | 0 | $650K | $632K | 915,705 | 915,705 |
Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Changes derive from the aggregate's top-25 slices and keyable positions only; unkeyable holdings are counted in the registry, not differenced. methodology §13F ↗
Book shape
2026-03-31 · concentration · vs tracked median · tick = median- Top-25 concentration
- 100.0%above median 80.0%
- Concentration index
- 1,744 bpsabove median 446 bps
- Positions with value
- 27 / 27median book 97.5 positions
Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.
null-value positions: 0holdings whose <value> did not parse — retained and counted, never zero-filled · top-N share ·§: 100.0% · HHI (bps) ·§: 1,744integer Herfindahl–Hirschman index in basis points over disclosed position values · QoQ moves: 32
Filing history
AVAILABLE QUARTERS| Period | Source |
|---|---|
| 2026-03-31 | EDGAR ↗ |
PLANNED sector rotation · Congress overlap · signals for this filer
Complete source filings on SEC EDGAR
The complete filing on EDGAR.
The position list above is served from the published Public Filings build — every position this filer reported for the selected quarter, as it reported it. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Serving this list is M2-CONTRACT §3, amended 2026-08-02; §3.1 keeps live EDGAR for filings newer than this build.
Open Alphabet Inc.'s 13F filings on SEC EDGAR ↗Notes on this data
Share changes
Compare consecutive quarters
Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.
Coverage
A snapshot, not current holdings
Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.
ViewPrior quarter not yet availableThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Reported positions — 2026-03-31
1–26 of 26 issuers · $4.0B disclosed value over 27 rows · 0 undisclosed-value rowsEvery row below carries ticker not yet mapped — stated once here rather than repeated on every row.
| KindClassification is not joined into this reported-position view. Use the changed-positions view to compare the two published quarters. | TickerThis list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names. | Issuera position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | WeightShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | Valuevalue undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Position changeShare change is available in the separate comparison view; it is not joined into this position list. | Wt | CongressThe congressional transaction join is unavailable in this build. |
|---|---|---|---|---|---|---|---|---|
| — | CMEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CME GROUP INC CME GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $1.0B | 3,484,020 | — | 25.6% | — | |
| — | PLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PLANET LABS PBC PLANET LABS PBC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $985M | 35,248,893 | — | 24.5% | — | |
| — | ASTSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AST SPACEMOBILE INC AST SPACEMOBILE INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $741M | 8,943,486 | — | 18.5% | — | |
| — | RVMDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REVOLUTION MEDICINES INC REVOLUTION MEDICINES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $320M | 3,292,525 | — | 8.0% | — | |
| — | ARMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARM HOLDINGS PLC ARM HOLDINGS PLC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $297M | 1,960,784 | — | 7.4% | — | |
| — | FRSHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FRESHWORKS INC | $130M | 16,206,643 | — | 3.2% | — | |
| — | PATHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UIPATH INC UIPATH INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $78.1M | 7,034,337 | — | 1.9% | — | |
| — | TEMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TEMPUS AI INC TEMPUS AI INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $70.1M | 1,551,102 | — | 1.7% | — | |
| — | PAYPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PAYPAY CORP PAYPAY CORP · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $66.7M | 3,125,000 | — | 1.7% | — | |
| — | — | GITLAB INC GITLAB INC · CLASS A COM CUSIP 37637K108 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $59.0M | 2,724,712 | — | 1.5% | — | |
| — | PRMEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PRIME MEDICINE INC PRIME MEDICINE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $57.6M | 16,562,498 | — | 1.4% | — | |
| — | — | ETHOS TECHNOLOGIES INC ETHOS TECHNOLOGIES INC · CL A CUSIP 29765A101 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $42.1M | 3,770,156 | — | 1.0% | — | |
| — | — | MAZE THERAPEUTICS INC MAZE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $41.4M | 1,388,583 | — | 1.0% | — | |
| — | BBOTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BRIDGEBIO ONCOLOGY THERAPEUT BRIDGEBIO ONCOLOGY THERAPEUT · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $25.3M | 2,823,126 | — | 0.6% | — | |
| — | RLAYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | RELAY THERAPEUTICS INC RELAY THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $15.6M | 1,564,173 | — | 0.4% | — | |
| — | — | MONTE ROSA THERAPEUTICS INC MONTE ROSA THERAPEUTICS INC · COM CUSIP 61225M102 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $11.3M | 684,275 | — | 0.3% | — | |
| — | — | VERA THERAPEUTICS INC VERA THERAPEUTICS INC · CL A CUSIP 92337R101 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $9.7M | 241,264 | — | 0.2% | — | |
| — | — | SANA BIOTECHNOLOGY INC SANA BIOTECHNOLOGY INC · COM CUSIP 799566104 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $8.1M | 2,812,500 | — | 0.2% | — | |
| — | — | BEAM THERAPEUTICS INC BEAM THERAPEUTICS INC · COM CUSIP 07373V105 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $7.7M | 321,604 | — | 0.2% | — | |
| — | — | LYELL IMMUNOPHARMA INC LYELL IMMUNOPHARMA INC · COM NEW CUSIP 55083R203 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $5.9M | 293,256 | — | 0.1% | — | |
| — | OSCRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | OSCAR HEALTH INC OSCAR HEALTH INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $5.5M | 481,988 | — | 0.1% | — | |
| — | FIGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FIGMA INC FIGMA INC · CLASS A COM STK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $4.6M | 215,582 | — | 0.1% | — | |
| — | — | SPERO THERAPEUTICS INC SPERO THERAPEUTICS INC · COM CUSIP 84833T103 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $2.1M | 889,979 | — | 0.1% | — | |
| — | — | HYPERFINE INC HYPERFINE INC · COM CL A CUSIP 44916K106 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $971K | 898,720 | — | 0.0% | — | |
| — | — | AUTOLUS THERAPEUTICS PLC AUTOLUS THERAPEUTICS PLC · SPON ADS CUSIP 05280R100 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $964K | 698,262 | — | 0.0% | — | |
| — | — | TENAYA THERAPEUTICS INC TENAYA THERAPEUTICS INC · COM CUSIP 87990A106 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $632K | 915,705 | — | 0.0% | — |
1–26 of 26 issuers · page 1 of 1
every row this filer reported for the quarter, as it reported it — cross-filer de-duplication is applied to issuer totals elsewhere and never deletes a row here
A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.
Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).